Chemomab Therapeutics Ltd - ADR
Chemomab Therapeutics Ltd - ADR Stock, NASDAQ:CMMB
Chemomab Therapeutics Ltd. operates as a clinical-stage biotech company. It discovers and develops therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The company was founded by Adi Mor on September 22, 2011 and is headquartered in Tel Aviv, Israel.